Outcomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19.
Identifieur interne : 000384 ( Main/Exploration ); précédent : 000383; suivant : 000385Outcomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19.
Auteurs : Frank L. Van De Veerdonk [Pays-Bas] ; Ilse J E. Kouijzer [Pays-Bas] ; Aline H. De Nooijer [Pays-Bas] ; Hans G. Van Der Hoeven [Pays-Bas] ; Coen Maas [Pays-Bas] ; Mihai G. Netea [Pays-Bas, Allemagne] ; Roger J M. Brüggemann [Pays-Bas]Source :
- JAMA network open [ 2574-3805 ] ; 2020.
Descripteurs français
- KwdFr :
- Adulte (MeSH), Adulte d'âge moyen (MeSH), Antagonistes du récepteur B2 de la bradykinine (usage thérapeutique), Betacoronavirus (MeSH), Bradykinine (analogues et dérivés), Bradykinine (métabolisme), Bradykinine (usage thérapeutique), Femelle (MeSH), Humains (MeSH), Infections à coronavirus (métabolisme), Infections à coronavirus (traitement médicamenteux), Infections à coronavirus (virologie), Mâle (MeSH), Oxygène (sang), Pandémies (MeSH), Pneumopathie virale (métabolisme), Pneumopathie virale (traitement médicamenteux), Pneumopathie virale (virologie), Récepteur de la bradykinine de type B2 (métabolisme), Sujet âgé (MeSH).
- MESH :
- analogues et dérivés : Bradykinine.
- métabolisme : Bradykinine, Infections à coronavirus, Pneumopathie virale, Récepteur de la bradykinine de type B2.
- sang : Oxygène.
- traitement médicamenteux : Infections à coronavirus, Pneumopathie virale.
- usage thérapeutique : Antagonistes du récepteur B2 de la bradykinine, Bradykinine.
- virologie : Infections à coronavirus, Pneumopathie virale.
- Adulte, Adulte d'âge moyen, Betacoronavirus, Femelle, Humains, Mâle, Pandémies, Sujet âgé.
English descriptors
- KwdEn :
- Adult (MeSH), Aged (MeSH), Betacoronavirus (MeSH), Bradykinin (analogs & derivatives), Bradykinin (metabolism), Bradykinin (therapeutic use), Bradykinin B2 Receptor Antagonists (therapeutic use), Coronavirus Infections (drug therapy), Coronavirus Infections (metabolism), Coronavirus Infections (virology), Female (MeSH), Humans (MeSH), Male (MeSH), Middle Aged (MeSH), Oxygen (blood), Pandemics (MeSH), Pneumonia, Viral (drug therapy), Pneumonia, Viral (metabolism), Pneumonia, Viral (virology), Receptor, Bradykinin B2 (metabolism).
- MESH :
- chemical , analogs & derivatives : Bradykinin.
- chemical , blood : Oxygen.
- chemical , metabolism : Bradykinin, Receptor, Bradykinin B2.
- chemical , therapeutic use : Bradykinin, Bradykinin B2 Receptor Antagonists.
- drug therapy : Coronavirus Infections, Pneumonia, Viral.
- metabolism : Coronavirus Infections, Pneumonia, Viral.
- virology : Coronavirus Infections, Pneumonia, Viral.
- Adult, Aged, Betacoronavirus, Female, Humans, Male, Middle Aged, Pandemics.
DOI: 10.1001/jamanetworkopen.2020.17708
PubMed: 32789513
PubMed Central: PMC7426743
Affiliations:
- Allemagne, Pays-Bas
- District de Cologne, Gueldre, Rhénanie-du-Nord-Westphalie, Utrecht (province)
- Bonn, Nimègue, Utrecht
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Outcomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19.</title><author><name sortKey="Van De Veerdonk, Frank L" sort="Van De Veerdonk, Frank L" uniqKey="Van De Veerdonk F" first="Frank L" last="Van De Veerdonk">Frank L. Van De Veerdonk</name><affiliation wicri:level="3"><nlm:affiliation>Radboudumc Institute for Molecular Life Sciences, Department of Internal Medicine, Radboudumc, Nijmegen, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Radboudumc Institute for Molecular Life Sciences, Department of Internal Medicine, Radboudumc, Nijmegen</wicri:regionArea><placeName><settlement type="city">Nimègue</settlement><region type="province" nuts="2">Gueldre</region></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Radboudumc Center for Infectious Diseases, Nijmegen, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Radboudumc Center for Infectious Diseases, Nijmegen</wicri:regionArea><placeName><settlement type="city">Nimègue</settlement><region type="province" nuts="2">Gueldre</region></placeName></affiliation></author><author><name sortKey="Kouijzer, Ilse J E" sort="Kouijzer, Ilse J E" uniqKey="Kouijzer I" first="Ilse J E" last="Kouijzer">Ilse J E. Kouijzer</name><affiliation wicri:level="3"><nlm:affiliation>Radboudumc Institute for Molecular Life Sciences, Department of Internal Medicine, Radboudumc, Nijmegen, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Radboudumc Institute for Molecular Life Sciences, Department of Internal Medicine, Radboudumc, Nijmegen</wicri:regionArea><placeName><settlement type="city">Nimègue</settlement><region type="province" nuts="2">Gueldre</region></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Radboudumc Center for Infectious Diseases, Nijmegen, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Radboudumc Center for Infectious Diseases, Nijmegen</wicri:regionArea><placeName><settlement type="city">Nimègue</settlement><region type="province" nuts="2">Gueldre</region></placeName></affiliation></author><author><name sortKey="De Nooijer, Aline H" sort="De Nooijer, Aline H" uniqKey="De Nooijer A" first="Aline H" last="De Nooijer">Aline H. De Nooijer</name><affiliation wicri:level="3"><nlm:affiliation>Radboudumc Institute for Molecular Life Sciences, Department of Internal Medicine, Radboudumc, Nijmegen, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Radboudumc Institute for Molecular Life Sciences, Department of Internal Medicine, Radboudumc, Nijmegen</wicri:regionArea><placeName><settlement type="city">Nimègue</settlement><region type="province" nuts="2">Gueldre</region></placeName></affiliation></author><author><name sortKey="Van Der Hoeven, Hans G" sort="Van Der Hoeven, Hans G" uniqKey="Van Der Hoeven H" first="Hans G" last="Van Der Hoeven">Hans G. Van Der Hoeven</name><affiliation wicri:level="3"><nlm:affiliation>Department of Intensive Care Medicine, Radboudumc, Nijmegen, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Department of Intensive Care Medicine, Radboudumc, Nijmegen</wicri:regionArea><placeName><settlement type="city">Nimègue</settlement><region type="province" nuts="2">Gueldre</region></placeName></affiliation></author><author><name sortKey="Maas, Coen" sort="Maas, Coen" uniqKey="Maas C" first="Coen" last="Maas">Coen Maas</name><affiliation wicri:level="3"><nlm:affiliation>Department of Intensive Care Medicine, University Medical Center Utrecht, Utrecht, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Department of Intensive Care Medicine, University Medical Center Utrecht, Utrecht</wicri:regionArea><placeName><settlement type="city">Utrecht</settlement><region nuts="2" type="province">Utrecht (province)</region></placeName></affiliation></author><author><name sortKey="Netea, Mihai G" sort="Netea, Mihai G" uniqKey="Netea M" first="Mihai G" last="Netea">Mihai G. Netea</name><affiliation wicri:level="3"><nlm:affiliation>Radboudumc Institute for Molecular Life Sciences, Department of Internal Medicine, Radboudumc, Nijmegen, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Radboudumc Institute for Molecular Life Sciences, Department of Internal Medicine, Radboudumc, Nijmegen</wicri:regionArea><placeName><settlement type="city">Nimègue</settlement><region type="province" nuts="2">Gueldre</region></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Radboudumc Center for Infectious Diseases, Nijmegen, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Radboudumc Center for Infectious Diseases, Nijmegen</wicri:regionArea><placeName><settlement type="city">Nimègue</settlement><region type="province" nuts="2">Gueldre</region></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Life and Medical Sciences Institute, Department for Genomics & Immunoregulation, University of Bonn, Bonn, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Life and Medical Sciences Institute, Department for Genomics & Immunoregulation, University of Bonn, Bonn</wicri:regionArea><placeName><region type="land" nuts="1">Rhénanie-du-Nord-Westphalie</region><region type="district" nuts="2">District de Cologne</region><settlement type="city">Bonn</settlement></placeName></affiliation></author><author><name sortKey="Bruggemann, Roger J M" sort="Bruggemann, Roger J M" uniqKey="Bruggemann R" first="Roger J M" last="Brüggemann">Roger J M. Brüggemann</name><affiliation wicri:level="3"><nlm:affiliation>Radboudumc Center for Infectious Diseases, Nijmegen, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Radboudumc Center for Infectious Diseases, Nijmegen</wicri:regionArea><placeName><settlement type="city">Nimègue</settlement><region type="province" nuts="2">Gueldre</region></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Radboud Institute for Health Sciences, Department of Pharmacy, Radboudumc, Nijmegen, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Radboud Institute for Health Sciences, Department of Pharmacy, Radboudumc, Nijmegen</wicri:regionArea><placeName><settlement type="city">Nimègue</settlement><region type="province" nuts="2">Gueldre</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32789513</idno><idno type="pmid">32789513</idno><idno type="doi">10.1001/jamanetworkopen.2020.17708</idno><idno type="pmc">PMC7426743</idno><idno type="wicri:Area/Main/Corpus">000682</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000682</idno><idno type="wicri:Area/Main/Curation">000682</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000682</idno><idno type="wicri:Area/Main/Exploration">000682</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Outcomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19.</title><author><name sortKey="Van De Veerdonk, Frank L" sort="Van De Veerdonk, Frank L" uniqKey="Van De Veerdonk F" first="Frank L" last="Van De Veerdonk">Frank L. Van De Veerdonk</name><affiliation wicri:level="3"><nlm:affiliation>Radboudumc Institute for Molecular Life Sciences, Department of Internal Medicine, Radboudumc, Nijmegen, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Radboudumc Institute for Molecular Life Sciences, Department of Internal Medicine, Radboudumc, Nijmegen</wicri:regionArea><placeName><settlement type="city">Nimègue</settlement><region type="province" nuts="2">Gueldre</region></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Radboudumc Center for Infectious Diseases, Nijmegen, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Radboudumc Center for Infectious Diseases, Nijmegen</wicri:regionArea><placeName><settlement type="city">Nimègue</settlement><region type="province" nuts="2">Gueldre</region></placeName></affiliation></author><author><name sortKey="Kouijzer, Ilse J E" sort="Kouijzer, Ilse J E" uniqKey="Kouijzer I" first="Ilse J E" last="Kouijzer">Ilse J E. Kouijzer</name><affiliation wicri:level="3"><nlm:affiliation>Radboudumc Institute for Molecular Life Sciences, Department of Internal Medicine, Radboudumc, Nijmegen, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Radboudumc Institute for Molecular Life Sciences, Department of Internal Medicine, Radboudumc, Nijmegen</wicri:regionArea><placeName><settlement type="city">Nimègue</settlement><region type="province" nuts="2">Gueldre</region></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Radboudumc Center for Infectious Diseases, Nijmegen, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Radboudumc Center for Infectious Diseases, Nijmegen</wicri:regionArea><placeName><settlement type="city">Nimègue</settlement><region type="province" nuts="2">Gueldre</region></placeName></affiliation></author><author><name sortKey="De Nooijer, Aline H" sort="De Nooijer, Aline H" uniqKey="De Nooijer A" first="Aline H" last="De Nooijer">Aline H. De Nooijer</name><affiliation wicri:level="3"><nlm:affiliation>Radboudumc Institute for Molecular Life Sciences, Department of Internal Medicine, Radboudumc, Nijmegen, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Radboudumc Institute for Molecular Life Sciences, Department of Internal Medicine, Radboudumc, Nijmegen</wicri:regionArea><placeName><settlement type="city">Nimègue</settlement><region type="province" nuts="2">Gueldre</region></placeName></affiliation></author><author><name sortKey="Van Der Hoeven, Hans G" sort="Van Der Hoeven, Hans G" uniqKey="Van Der Hoeven H" first="Hans G" last="Van Der Hoeven">Hans G. Van Der Hoeven</name><affiliation wicri:level="3"><nlm:affiliation>Department of Intensive Care Medicine, Radboudumc, Nijmegen, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Department of Intensive Care Medicine, Radboudumc, Nijmegen</wicri:regionArea><placeName><settlement type="city">Nimègue</settlement><region type="province" nuts="2">Gueldre</region></placeName></affiliation></author><author><name sortKey="Maas, Coen" sort="Maas, Coen" uniqKey="Maas C" first="Coen" last="Maas">Coen Maas</name><affiliation wicri:level="3"><nlm:affiliation>Department of Intensive Care Medicine, University Medical Center Utrecht, Utrecht, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Department of Intensive Care Medicine, University Medical Center Utrecht, Utrecht</wicri:regionArea><placeName><settlement type="city">Utrecht</settlement><region nuts="2" type="province">Utrecht (province)</region></placeName></affiliation></author><author><name sortKey="Netea, Mihai G" sort="Netea, Mihai G" uniqKey="Netea M" first="Mihai G" last="Netea">Mihai G. Netea</name><affiliation wicri:level="3"><nlm:affiliation>Radboudumc Institute for Molecular Life Sciences, Department of Internal Medicine, Radboudumc, Nijmegen, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Radboudumc Institute for Molecular Life Sciences, Department of Internal Medicine, Radboudumc, Nijmegen</wicri:regionArea><placeName><settlement type="city">Nimègue</settlement><region type="province" nuts="2">Gueldre</region></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Radboudumc Center for Infectious Diseases, Nijmegen, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Radboudumc Center for Infectious Diseases, Nijmegen</wicri:regionArea><placeName><settlement type="city">Nimègue</settlement><region type="province" nuts="2">Gueldre</region></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Life and Medical Sciences Institute, Department for Genomics & Immunoregulation, University of Bonn, Bonn, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Life and Medical Sciences Institute, Department for Genomics & Immunoregulation, University of Bonn, Bonn</wicri:regionArea><placeName><region type="land" nuts="1">Rhénanie-du-Nord-Westphalie</region><region type="district" nuts="2">District de Cologne</region><settlement type="city">Bonn</settlement></placeName></affiliation></author><author><name sortKey="Bruggemann, Roger J M" sort="Bruggemann, Roger J M" uniqKey="Bruggemann R" first="Roger J M" last="Brüggemann">Roger J M. Brüggemann</name><affiliation wicri:level="3"><nlm:affiliation>Radboudumc Center for Infectious Diseases, Nijmegen, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Radboudumc Center for Infectious Diseases, Nijmegen</wicri:regionArea><placeName><settlement type="city">Nimègue</settlement><region type="province" nuts="2">Gueldre</region></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Radboud Institute for Health Sciences, Department of Pharmacy, Radboudumc, Nijmegen, the Netherlands.</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Radboud Institute for Health Sciences, Department of Pharmacy, Radboudumc, Nijmegen</wicri:regionArea><placeName><settlement type="city">Nimègue</settlement><region type="province" nuts="2">Gueldre</region></placeName></affiliation></author></analytic><series><title level="j">JAMA network open</title><idno type="eISSN">2574-3805</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term><term>Aged (MeSH)</term><term>Betacoronavirus (MeSH)</term><term>Bradykinin (analogs & derivatives)</term><term>Bradykinin (metabolism)</term><term>Bradykinin (therapeutic use)</term><term>Bradykinin B2 Receptor Antagonists (therapeutic use)</term><term>Coronavirus Infections (drug therapy)</term><term>Coronavirus Infections (metabolism)</term><term>Coronavirus Infections (virology)</term><term>Female (MeSH)</term><term>Humans (MeSH)</term><term>Male (MeSH)</term><term>Middle Aged (MeSH)</term><term>Oxygen (blood)</term><term>Pandemics (MeSH)</term><term>Pneumonia, Viral (drug therapy)</term><term>Pneumonia, Viral (metabolism)</term><term>Pneumonia, Viral (virology)</term><term>Receptor, Bradykinin B2 (metabolism)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte (MeSH)</term><term>Adulte d'âge moyen (MeSH)</term><term>Antagonistes du récepteur B2 de la bradykinine (usage thérapeutique)</term><term>Betacoronavirus (MeSH)</term><term>Bradykinine (analogues et dérivés)</term><term>Bradykinine (métabolisme)</term><term>Bradykinine (usage thérapeutique)</term><term>Femelle (MeSH)</term><term>Humains (MeSH)</term><term>Infections à coronavirus (métabolisme)</term><term>Infections à coronavirus (traitement médicamenteux)</term><term>Infections à coronavirus (virologie)</term><term>Mâle (MeSH)</term><term>Oxygène (sang)</term><term>Pandémies (MeSH)</term><term>Pneumopathie virale (métabolisme)</term><term>Pneumopathie virale (traitement médicamenteux)</term><term>Pneumopathie virale (virologie)</term><term>Récepteur de la bradykinine de type B2 (métabolisme)</term><term>Sujet âgé (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Bradykinin</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Oxygen</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Bradykinin</term><term>Receptor, Bradykinin B2</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Bradykinin</term><term>Bradykinin B2 Receptor Antagonists</term></keywords><keywords scheme="MESH" qualifier="analogues et dérivés" xml:lang="fr"><term>Bradykinine</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Bradykinine</term><term>Infections à coronavirus</term><term>Pneumopathie virale</term><term>Récepteur de la bradykinine de type B2</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Oxygène</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à coronavirus</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antagonistes du récepteur B2 de la bradykinine</term><term>Bradykinine</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Infections à coronavirus</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Betacoronavirus</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Pandemics</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Betacoronavirus</term><term>Femelle</term><term>Humains</term><term>Mâle</term><term>Pandémies</term><term>Sujet âgé</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32789513</PMID><DateCompleted><Year>2020</Year><Month>08</Month><Day>26</Day></DateCompleted><DateRevised><Year>2020</Year><Month>08</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2574-3805</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>8</Issue><PubDate><Year>2020</Year><Month>08</Month><Day>03</Day></PubDate></JournalIssue><Title>JAMA network open</Title><ISOAbbreviation>JAMA Netw Open</ISOAbbreviation></Journal><ArticleTitle>Outcomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19.</ArticleTitle><Pagination><MedlinePgn>e2017708</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2020.17708</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>van de Veerdonk</LastName><ForeName>Frank L</ForeName><Initials>FL</Initials><AffiliationInfo><Affiliation>Radboudumc Institute for Molecular Life Sciences, Department of Internal Medicine, Radboudumc, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Radboudumc Center for Infectious Diseases, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kouijzer</LastName><ForeName>Ilse J E</ForeName><Initials>IJE</Initials><AffiliationInfo><Affiliation>Radboudumc Institute for Molecular Life Sciences, Department of Internal Medicine, Radboudumc, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Radboudumc Center for Infectious Diseases, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Nooijer</LastName><ForeName>Aline H</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Radboudumc Institute for Molecular Life Sciences, Department of Internal Medicine, Radboudumc, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Hoeven</LastName><ForeName>Hans G</ForeName><Initials>HG</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Radboudumc, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maas</LastName><ForeName>Coen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, University Medical Center Utrecht, Utrecht, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Netea</LastName><ForeName>Mihai G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Radboudumc Institute for Molecular Life Sciences, Department of Internal Medicine, Radboudumc, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Radboudumc Center for Infectious Diseases, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Life and Medical Sciences Institute, Department for Genomics & Immunoregulation, University of Bonn, Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brüggemann</LastName><ForeName>Roger J M</ForeName><Initials>RJM</Initials><AffiliationInfo><Affiliation>Radboudumc Center for Infectious Diseases, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Radboud Institute for Health Sciences, Department of Pharmacy, Radboudumc, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Netw Open</MedlineTA><NlmUniqueID>101729235</NlmUniqueID><ISSNLinking>2574-3805</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D065094">Bradykinin B2 Receptor Antagonists</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D043782">Receptor, Bradykinin B2</NameOfSubstance></Chemical><Chemical><RegistryNumber>7PG89G35Q7</RegistryNumber><NameOfSubstance UI="C065679">icatibant</NameOfSubstance></Chemical><Chemical><RegistryNumber>S88TT14065</RegistryNumber><NameOfSubstance UI="D010100">Oxygen</NameOfSubstance></Chemical><Chemical><RegistryNumber>S8TIM42R2W</RegistryNumber><NameOfSubstance UI="D001920">Bradykinin</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName><SupplMeshName Type="Protocol" UI="C000705127">COVID-19 drug treatment</SupplMeshName><SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001920" MajorTopicYN="N">Bradykinin</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs & derivatives</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D065094" MajorTopicYN="N">Bradykinin B2 Receptor Antagonists</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010100" MajorTopicYN="N">Oxygen</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043782" MajorTopicYN="N">Receptor, Bradykinin B2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32789513</ArticleId><ArticleId IdType="pii">2769237</ArticleId><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.17708</ArticleId><ArticleId IdType="pmc">PMC7426743</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cell. 2020 Apr 16;181(2):271-280.e8</Citation><ArticleIdList><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Radiol. 2020 Aug;30(8):4407-4416</Citation><ArticleIdList><ArticleId IdType="pubmed">32215691</ArticleId></ArticleIdList></Reference><Reference><Citation>Elife. 2020 Apr 27;9:</Citation><ArticleIdList><ArticleId IdType="pubmed">32338605</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Allemagne</li><li>Pays-Bas</li></country><region><li>District de Cologne</li><li>Gueldre</li><li>Rhénanie-du-Nord-Westphalie</li><li>Utrecht (province)</li></region><settlement><li>Bonn</li><li>Nimègue</li><li>Utrecht</li></settlement></list><tree><country name="Pays-Bas"><region name="Gueldre"><name sortKey="Van De Veerdonk, Frank L" sort="Van De Veerdonk, Frank L" uniqKey="Van De Veerdonk F" first="Frank L" last="Van De Veerdonk">Frank L. Van De Veerdonk</name></region><name sortKey="Bruggemann, Roger J M" sort="Bruggemann, Roger J M" uniqKey="Bruggemann R" first="Roger J M" last="Brüggemann">Roger J M. Brüggemann</name><name sortKey="Bruggemann, Roger J M" sort="Bruggemann, Roger J M" uniqKey="Bruggemann R" first="Roger J M" last="Brüggemann">Roger J M. Brüggemann</name><name sortKey="De Nooijer, Aline H" sort="De Nooijer, Aline H" uniqKey="De Nooijer A" first="Aline H" last="De Nooijer">Aline H. De Nooijer</name><name sortKey="Kouijzer, Ilse J E" sort="Kouijzer, Ilse J E" uniqKey="Kouijzer I" first="Ilse J E" last="Kouijzer">Ilse J E. Kouijzer</name><name sortKey="Kouijzer, Ilse J E" sort="Kouijzer, Ilse J E" uniqKey="Kouijzer I" first="Ilse J E" last="Kouijzer">Ilse J E. Kouijzer</name><name sortKey="Maas, Coen" sort="Maas, Coen" uniqKey="Maas C" first="Coen" last="Maas">Coen Maas</name><name sortKey="Netea, Mihai G" sort="Netea, Mihai G" uniqKey="Netea M" first="Mihai G" last="Netea">Mihai G. Netea</name><name sortKey="Netea, Mihai G" sort="Netea, Mihai G" uniqKey="Netea M" first="Mihai G" last="Netea">Mihai G. Netea</name><name sortKey="Van De Veerdonk, Frank L" sort="Van De Veerdonk, Frank L" uniqKey="Van De Veerdonk F" first="Frank L" last="Van De Veerdonk">Frank L. Van De Veerdonk</name><name sortKey="Van Der Hoeven, Hans G" sort="Van Der Hoeven, Hans G" uniqKey="Van Der Hoeven H" first="Hans G" last="Van Der Hoeven">Hans G. Van Der Hoeven</name></country><country name="Allemagne"><region name="Rhénanie-du-Nord-Westphalie"><name sortKey="Netea, Mihai G" sort="Netea, Mihai G" uniqKey="Netea M" first="Mihai G" last="Netea">Mihai G. Netea</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidSeniorV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000384 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000384 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidSeniorV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32789513
|texte= Outcomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32789513" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidSeniorV1
| This area was generated with Dilib version V0.6.37. |  |